Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DISPOSA-SPEC

K-Number: K840593 · 1984-07-13

Decision Date1984-07-13
Product CodeERA
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

DISPOSA-SPEC is the device name listed in this FDA 510(k) record. The listed applicant is Plasti-Products, Inc.. It received FDA 510(k) clearance on 1984-07-13 under 510(k) number K840593. The device is classified under product code ERA. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DISPOSA-SPEC?

DISPOSA-SPEC is a medical device that received FDA 510(k) clearance on 1984-07-13. The listed applicant is Plasti-Products, Inc.. The 510(k) number is K840593.

When did DISPOSA-SPEC receive FDA 510(k) clearance?

DISPOSA-SPEC received FDA 510(k) clearance on 1984-07-13, under 510(k) number K840593.

Who is the listed applicant for DISPOSA-SPEC?

The FDA 510(k) record lists Plasti-Products, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for DISPOSA-SPEC?

The FDA product code for DISPOSA-SPEC is ERA.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Plasti-Products, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: ERA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑